What are the alternative treatment options for relapsed or elderly AML patients?
The last year in CLL
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
Novel CLL therapy highlights from ASH 2017
The use of social media to reach out to patients and help improve clinical trials